Baxter International Inc. says that a blood product it was testing failed to slow mental decline or to preserve physical function in a major study of 390 patients with mild to moderate Alzheimer's disease.
Cancer and heart disease are bigger killers, but Alzheimer's is the most expensive malady in the U.S., costing families and society $157 billion to $215 billion a year, according to a new study that looked at this in unprecedented detail.
When seniors with dementia wander off without warning, it can be a frightening experience for their family and caregivers. In fact, as many as three out of every five people with dementia will go missing at some point.
A staggering 1 in 3 seniors dies with Alzheimer's disease or other types of dementia, says a new report that highlights the impact the mind-destroying disease is having on the rapidly aging population.
Could the key to preventing the onset of Alzheimer’s disease be in your feet?
A new study finds that older adults who exercise just a half hour a day are nearly 40 per cent less likely to develop Alzheimer’s than those who don’t exercise at all.
It has the makings of a science fiction movie: Zap someone's brain with mild jolts of electricity to try to stave off the creeping memory loss of Alzheimer's disease.
A rare mutation of a gene that’s normally linked to inflammation could triple the risk of Alzheimer’s disease, according to new research from an international team of scientists.
Combined results from two studies of an experimental Alzheimer's drug suggest it might modestly slow mental decline, especially in patients with mild disease.
Just after 10 p.m., when most people their age are going to sleep, a group of elderly folks suffering from dementia are just getting started, dancing and shaking tambourines and maracas in a raucous version of 'La Bamba.'
An experimental drug that failed to stop mental decline in Alzheimer's patients also showed some potential benefit, fuller results of two major studies now show.
